ET 743
| ET 743 | |
|---|---|
| Term | ET 743 |
| Short definition | ET 743 - A medicine used to treat liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be surgically removed or that have spread to other parts of the body. It is used in patients who have already been treated with other anticancer medicines. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
ET 743 - A medicine used to treat liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be surgically removed or that have spread to other parts of the body. It is used in patients who have already been treated with other anticancer medicines. It is also being studied in the treatment of other types of cancer. ET 743 can kill cancer cells by damaging their DNA and stopping them from dividing. It's a type of alkylating agent. Also called ecteinascidin, trabectedin and yondelis
External links
- Medical encyclopedia article on ET 743
- Wikipedia's article - ET 743
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski